ClinicalTrials.Veeva

Menu

EDOF and Multifocal IOL Study

Medical University of Vienna logo

Medical University of Vienna

Status

Completed

Conditions

Age-related Cataract

Treatments

Procedure: phacoemulsification and intraocular lens implantation
Device: intraocular lens implantation

Study type

Interventional

Funder types

Other

Identifiers

NCT05573529
1163/2020

Details and patient eligibility

About

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.

Enrollment

50 patients

Sex

All

Ages

50 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Bilateral age-related cataract for which phacoemulsification extraction and posterior IOL implantation has planned
  • Age 50-90
  • Visual potential in both eyes of 20/30 or better as determined by investigators estimation
  • Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant

Exclusion criteria

  • Preceding ocular surgery or trauma
  • Relevant other ophthalmic diseases (such as retinal degenerations, etc.)
  • Uncontrolled systemic or ocular disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

Edof IOL vs. multifocal IOL I
Experimental group
Description:
The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. In Arm one (I) participants will receive Edof IOL one (I) vs. multifocal IOL one (I).
Treatment:
Device: intraocular lens implantation
Procedure: phacoemulsification and intraocular lens implantation
Edof IOL vs. multifocal IOL II
Experimental group
Description:
The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. In Arm two (II) participants will receive Edof IOL one (I) vs. multifocal IOL two (II).
Treatment:
Device: intraocular lens implantation
Procedure: phacoemulsification and intraocular lens implantation

Trial contacts and locations

1

Loading...

Central trial contact

Christina Leydolt, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems